Anti-Hypertensive Drugs Market Key Trend by Pharmacological Class, Hypertension Type, Disease Source, Analysis and Forecast to 2022

Pune, India — 02/13/2018 — The Global Anti-Hypertensive Drugs Market was valued at $32.2 billion in 2015, and is expected to reach $ 38.9 billion by 2022. Thus the market is expected to perform sluggish growth at a CAGR of 2.73% from 2016 to 2022.

Anti-hypertensive drugs are used to treat hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial blood pressure at or greater than 140/90 mm Hg for adults.

There exact cause of essential hypertension is unknown but is blamed on unhealthy lifestyle and ageing. The major market driving factor for secondary hypertension are greater detection and early diagnosis. Rise in the prevalence diseases such as kidney problems, thyroid problems, adrenal gland tumors, heart ailments, chronic alcohol use etc. in which anti-hypertensive are used are some of the other factors driving the growth of the market.

The constraints however are overwhelming and include patent expiries such as Actelion's Tracleer (2015), and United Therapeutic's Remodulin (2014). Other blockbuster's such as Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc. are also off-patent.

Access Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2347 .

Regional Analysis of Global Anti-Hypertensive Drugs Market:

Globally North America is the largest market for global anti-hypertensive drugs. Europe is the second-largest market for global anti-hypertensive drugs. The near future market for anti-hypertensive drugs will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future.

Key Players for Global Anti-Hypertensive Drugs Market:

Novartis AG,
Daiichi Sankyo Company Limited,
Acetelion Ltd,
Boehringer Ingelheim,
Sanofi S.A.,
Astra Zeneca plc,
Ranbaxy Laboratories Limited Inc.,
Takeda Pharmaceuticals Company Limited,
Pfizer Inc.

The report for Global Anti-Hypertensive Drugs Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/2347 .

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Add Comment